Questions over safety and effectiveness of new Alzheimer’s drug

The safety and effectiveness of donanemab—an Alzheimer’s drug recently approved by the US Food & Drug Administration (FDA)—is called into question in an investigation published by The BMJ.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup